المؤلفون: Cheah C.Y., Marlton P., Trotman J., Opat S.

مصطلحات الفهرس: positron emission tomography, cancer prognosis, cancer recurrence, cancer staging, cancer survival, Chlamydia psittaci, computer assisted tomography, drug effect, drug targeting, event free survival, fluorescence in situ hybridization, Helicobacter pylori, Hepatitis C virus, human, mantle cell lymphoma/di [Diagnosis], mantle cell lymphoma/dt [Drug Therapy], marginal zone lymphoma/di [Diagnosis], marginal zone lymphoma/dt [Drug Therapy], multiple cycle treatment, nonhuman, overall survival, priority journal, progression free survival, review, survival time, treatment duration, treatment outcome, treatment planning, tumor biopsy, bendamustine/cb [Drug Combination], bendamustine/dt [Drug Therapy], cyclophosphamide/cb [Drug Combination], cyclophosphamide/dt [Drug Therapy], cytarabine/dt [Drug Therapy], doxorubicin/cb [Drug Combination], doxorubicin/dt [Drug Therapy], fludarabine/cb [Drug Combination], fludarabine/dt [Drug Therapy], methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], prednisolone/cb [Drug Combination], prednisolone/dt [Drug Therapy], prednisone/cb [Drug Combination], prednisone/dt [Drug Therapy], rituximab/cb [Drug Combination], rituximab/dt [Drug Therapy], vincristine/cb [Drug Combination], vincristine/dt [Drug Therapy], Australia, Borrelia burgdorferi, Campylobacter jejuni, cancer combination chemotherapy, cancer immunotherapy, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35992
Internal Medicine Journal
Click here for full text options
LibKey Link

المؤلفون: Cheah C.Y., Marlton P., Trotman J., Opat S.

مصطلحات الفهرس: positron emission tomography, cancer prognosis, cancer recurrence, cancer staging, cancer survival, Chlamydia psittaci, computer assisted tomography, drug effect, drug targeting, event free survival, fluorescence in situ hybridization, Helicobacter pylori, Hepatitis C virus, human, mantle cell lymphoma/di [Diagnosis], mantle cell lymphoma/dt [Drug Therapy], marginal zone lymphoma/di [Diagnosis], marginal zone lymphoma/dt [Drug Therapy], multiple cycle treatment, nonhuman, overall survival, priority journal, progression free survival, review, survival time, treatment duration, treatment outcome, treatment planning, tumor biopsy, bendamustine/cb [Drug Combination], bendamustine/dt [Drug Therapy], cyclophosphamide/cb [Drug Combination], cyclophosphamide/dt [Drug Therapy], cytarabine/dt [Drug Therapy], doxorubicin/cb [Drug Combination], doxorubicin/dt [Drug Therapy], fludarabine/cb [Drug Combination], fludarabine/dt [Drug Therapy], methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], prednisolone/cb [Drug Combination], prednisolone/dt [Drug Therapy], prednisone/cb [Drug Combination], prednisone/dt [Drug Therapy], rituximab/cb [Drug Combination], rituximab/dt [Drug Therapy], vincristine/cb [Drug Combination], vincristine/dt [Drug Therapy], Australia, Borrelia burgdorferi, Campylobacter jejuni, cancer combination chemotherapy, cancer immunotherapy, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35992
Internal Medicine Journal
LibKey Link